Andera Partners Long-Term Concentrated

Location: Paris, France

CIK: 0001757283 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 11, 2026

Total Value: $177M (100.0% shares, 0.0% debt)

Holdings (7)

KMTS KESTRA MED TECHNOLOGIES LTD 30.4%

Value $53.72M Shares 2,695,192 Share Price $19.93 Est. Cost/Share $25.63 Unrealized @ Report Date -22.2%

EVMN EVOMMUNE INC 24.7%

Value $43.62M Shares 1,897,362 Share Price $22.99 Est. Cost/Share $18.78 Unrealized @ Report Date +22.4%

MLYS MINERALYS THERAPEUTICS INC 24.4%

Value $43.13M Shares 1,591,917 Share Price $27.09 Est. Cost/Share $40.10 Unrealized @ Report Date -32.4%

AGMB AGOMAB THERAPEUTICS NV 9.1%

Value $16.14M Shares 1,538,702 Share Price $10.49 Est. Cost/Share $14.16 Unrealized @ Report Date -25.9%

IVA INVENTIVA SA 5.7%

Value $10.09M Shares 1,818,181 Share Price $5.55 Est. Cost/Share $4.65 Unrealized @ Report Date +19.4%

ABVX ABIVAX SA 4.9%

Value $8.699M Shares 78,125 Share Price $111.35 Est. Cost/Share $109.11 Unrealized @ Report Date +2.1%

NYXH NYXOAH S A 0.9%

Value $1.524M Shares 522,057 Share Price $2.92 Est. Cost/Share $4.22 Unrealized @ Report Date -30.8%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
KMTS	KESTRA MED TECHNOLOGIES LTD	2,695,192	$53.72M	30.4%	$19.93	$25.63	-22.2%	SHS	G52441105
EVMN	EVOMMUNE INC	1,897,362	$43.62M	24.7%	$22.99	$18.78	+22.4%	COM SHS	30054Y107
MLYS	MINERALYS THERAPEUTICS INC	1,591,917	$43.13M	24.4%	$27.09	$40.10	-32.4%	COM	603170101
AGMB	AGOMAB THERAPEUTICS NV	1,538,702	$16.14M	9.1%	$10.49	$14.16	-25.9%	SPONSORED ADS	00860C102
IVA	INVENTIVA SA	1,818,181	$10.09M	5.7%	$5.55	$4.65	+19.4%	ADS	46124U107
ABVX	ABIVAX SA	78,125	$8.699M	4.9%	$111.35	$109.11	+2.1%	SPONSORED ADS	00370M103
NYXH	NYXOAH S A	522,057	$1.524M	0.9%	$2.92	$4.22	-30.8%	SHS	B6S7WD106